Skip to main content
Erschienen in: Reactions Weekly 1/2014

01.12.2014 | Case report

Norfloxacin

Rowell syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Baroni A, et al. Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: The enigma of the Rowell syndrome. Journal der Deutschen Dermatologischen Gesellschaft 12: 1039-1042, No. 11, Nov 2014. Available from: URL: http://doi.org/10.1111/ddg.12392 - Italy Baroni A, et al. Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: The enigma of the Rowell syndrome. Journal der Deutschen Dermatologischen Gesellschaft 12: 1039-1042, No. 11, Nov 2014. Available from: URL: http://​doi.​org/​10.​1111/​ddg.​12392 - Italy
Metadaten
Titel
Norfloxacin
Rowell syndrome: case report
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-014-5969-x

Weitere Artikel der Ausgabe 1/2014

Reactions Weekly 1/2014 Zur Ausgabe

Case report

Fingolimod

Case report

Rituximab

Case report

Phenytoin